Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«TLR9

Below is an extended TLR9 patents listing. Click here to return to the gene page.

Patents :

US Patent No.Title
7470674 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
7521443 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
7521444 Compounds for the treatment of hepatitis C
7524827 Methods and compositions for the inhibition of gene expression
7524828 Immunostimulatory nucleic acid molecules
7527801 Norovirus and Sapovirus antigens
7537767 Melan-A- carrier conjugates
7537768 Influenza virus vaccine composition and methods of use
7538103 Compounds for the treatment of hepatitis C
7541351 Compounds for the treatment of hepatitis C
7541352 Compounds for the treatment of hepatitis C
7521442 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
7517872 Compounds for the treatment of hepatitis C
7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
7485432 Selective modulation of TLR-mediated biological activity
7498315 Methods and compositions for the inhibition of gene expression
7498409 Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
7498425 Immunostimulatory oligonucleotide multimers
7498426 Immunostimulatory oligonucleotide multimers
7507872 Transgenic toll-like receptor 9 (TLR9) mice
7510858 IRAK 1c splice variant and its use
7514099 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7517520 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
7517861 Immunostimulatory nucleic acid molecules
7541353 Compounds for the treatment of hepatitis C
7547690 Compounds for the treatment of Hepatitis C
7576068 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
7579450 Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells
7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
7585504 High affinity antibodies against HMGB1 and methods of use thereof
7585847 Immunostimulatory nucleic acids for the treatment of asthma and allergy
7592003 Regulation of toll-like receptors on stem cells
7592326 Method for stimulating the immune, inflammatory or neuroprotective response
7605138 Nucleic acid compositions for stimulating immune responses
7608750 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
7576066 Nucleic acid compositions for stimulating immune responses
7576057 Cyclic peptides
7569681 Caterpiller gene family
7550501 Compounds and methods for treating toll-like receptor 2-related diseases and conditions
7553932 Methods of treating viral infection with IL-10 receptor antagonists
7557086 Method and peptide for regulating cellular activity
7557258 Endotoxin-nonresponsive model animal
7560436 Methods of treating gastrointestinal inflammation
7563448 Modified vaccinia ankara expressing P53 in cancer immunotherapy
7566694 Anti-pathogen treatments
7566702 Immunostimulatory oligonucleotide multimers
7566703 Semi-soft C-class immunostimulatory oligonucleotides
7569553 Nucleic acid compositions for stimulating immune responses
7612181 Dual variable domain immunoglobulin and uses thereof

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.